21 July 2021
Apollon Formularies Plc
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a
Stephen was a Co-Founder and President of Apollon Formularies Inc. in the US, established in 2014. He was instrumental in the international expansion of Apollon Formularies to
Stephen is Co-Founder and President of Doc's Place International, an award-winning health and wellness resort located in Negril,
Stephen is also the Founder and CEO of CBev Ventures Inc., a medical cannabis beverage company offering the High Spirits brand of drinks.
Stene joined Apollon in December 2020 as Head of Corporate Development where he has already helped foster and develop strategic relationships within the medical cannabis arena in
He started his career in the Navy where he qualified as a South African Navy Diver in 1992. After leaving the Navy, he began a long career spanning 20 years in Real Estate where he acquired a wide range of expertise in property development, real estate finance, debt and equity structuring and corporate finance.
He brings substantial senior level operational experience to the team. He honed his skills in residential property development, moving into commercial development in 2010. During this period, he successfully completed 15 projects for Standard Bank premises, as an independent consultant for the Industrial and Commercial Bank of China - a Forbes no.1 Company in 2013. From 2006 to 2015 he was responsible for a multi-property portfolio of over a hundred properties, initially in the capacity as trustee, but was subsequently elected as Chairman in 2011, presiding over this role until 2015.
Stene also has strong entrepreneurial experience with a history of successful start-ups and has been a key player in enabling strategic growth for new ventures in various capacities. He is the Co-Founder and Director of Eyecom LED Solutions, which has grown to be the largest provider of premier specialist LED technology on the African continent with operations expanding into
In 2015 he joined Viridi Data Centres in the role of COO where he was pivotal in establishing its new business in
In 2018 he took a role as Operations Director at Peritus Corporate Finance where he had oversight of all operational activities and was able to further hone his skills in corporate finance, debt acquisition, and equity finance on a wide range of complex transactions.
Stephen D. Barnhill, M.D., CEO of Apollon, commented, "We are pleased to bring these exceptional people, who have both been pivotal in Apollon's success thus far, onto our executive management team. Apollon's strategy for growth is something we are giving a lot of attention to and utilising the skills and experience that Stephen and Stene possess, I am confident that we will start to see significant global expansion and revenue generation."
The Directors of the Company are responsible for this announcement.
- End -
For additional information, please visit www.apollon.org.uk or contact:
Tel: +44 207 907 9314
Stene Jacobs firstname.lastname@example.org
Peterhouse Capital Limited (Corporate Adviser)
Tel: +44 207 220 9795
Guy Miller email@example.com
Blytheweigh (Financial PR/IR-London)
Tel: +44 207 138 3204
Tim Blythe firstname.lastname@example.org
Megan Ray email@example.com
About Apollon and Apollon Jamaica
Apollon Formularies plc is an international medical cannabis company headquartered in the United Kingdom. Apollon Formularies Jamaica Limited is a pharmaceutical company incorporated and operating in the Commonwealth of Jamaica. Apollon Jamaica is licensed by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate, perform research and development, process, and sell medical cannabis therapeutic products that include legal medical cannabis in order to treat various illnesses under medical supervision. Apollon and Apollon Jamaica are parties to a Commitment Agreement whereby Apollon is entitled to 95% of Apollon Jamaica's Net Profits, and per a Stock Pledge Agreement that includes Stephen D. Barnhill, M.D., Apollon is to be assigned the entire 49% equity interest of Apollon Jamaica held by Dr. Barnhill, which is the maximum interest in a medical cannabis company allowed to be held by a non-Jamaican, upon the CLA approving the assignment.